Budget cuts at the Medicines and Healthcare Products Regulatory Agency, the UK’s medicines regulator, come at “a strange time” as the organisation needs the capacity to handle complex new EU regulations, says Professor Derek Hill (UCL Medical Physics & Biomedical Engineering).
Read: FT (£)
Close
